Rapid and profound drop of HCV RNA viraemia induced by high dose of consensus interferon just before starting pegylated interferon plus ribavirin in chronic hepatitis C patients previously resistant to combined therapy:: preliminary report. (2002)
- Authors:
- USP affiliated authors: CARRILHO, FLAIR JOSE - FM ; SILVA, LUIZ CAETANO DA - FM ; NITA, SUZANE KIOKO ONO - FM
- Unidade: FM
- Assunto: RNA
- Language: Inglês
- Imprenta:
- Conference titles: Therapies for viral hepatitits
-
ABNT
SILVA, L. C. da et al. Rapid and profound drop of HCV RNA viraemia induced by high dose of consensus interferon just before starting pegylated interferon plus ribavirin in chronic hepatitis C patients previously resistant to combined therapy:: preliminary report. 2002, Anais.. Boston,: Faculdade de Medicina, Universidade de São Paulo, 2002. . Acesso em: 12 jan. 2026. -
APA
Silva, L. C. da, Nita, S. K. O., Pinho, J. R. R., Carrilho, F. J., & Medeiros, J. E. (2002). Rapid and profound drop of HCV RNA viraemia induced by high dose of consensus interferon just before starting pegylated interferon plus ribavirin in chronic hepatitis C patients previously resistant to combined therapy:: preliminary report. In . Boston,: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Silva LC da, Nita SKO, Pinho JRR, Carrilho FJ, Medeiros JE. Rapid and profound drop of HCV RNA viraemia induced by high dose of consensus interferon just before starting pegylated interferon plus ribavirin in chronic hepatitis C patients previously resistant to combined therapy:: preliminary report. 2002 ;[citado 2026 jan. 12 ] -
Vancouver
Silva LC da, Nita SKO, Pinho JRR, Carrilho FJ, Medeiros JE. Rapid and profound drop of HCV RNA viraemia induced by high dose of consensus interferon just before starting pegylated interferon plus ribavirin in chronic hepatitis C patients previously resistant to combined therapy:: preliminary report. 2002 ;[citado 2026 jan. 12 ] - Searching for chronic hepatitis B patients in a low prevalence area: role of racial origin
- High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study
- A twelve-week period of follow-up after an end of treatment response (ETR) in patients with chronic hepatitis C (CH-C) submitted to combined therapy is a reliable period to characterize a sustained response
- A prospective study of the prevalence of hepatitis B and C virus co-infection among patients with chronic renal disease under hemodialysis
- A phylogenetic study of hepatitis B virus in chronically infected Brazilian patients of Western and Asian descent
- A twelve-week period of follow-up after an end-of-treatment response in patients with chronic hepatitis C submitted to combined therapy is a reliable period to characterize a sustained response.
- Rapid and profound drop HCV RNA viremia induced by high dose of consensus IFN (CIFN) just before starting pegylated interferon (PEG-IFN) plus ribavirin (RBV) in chronic hepatitits C patients (pts) previously resistant to combined therapy (IFN+RBV): preliminary report
- Unpredictable outcome in lamivudine (LAM): resistant patients under high daily doses & early effects of combined therapy of lam plus pegylated interferon
- Tratamento das hepatites virais B e D
- Early clearance kinetics of hepatitis C virus (HCV) in patients with chronic hepatitis C under therapy with pegylated-interferon (PEG-IFN) alpha-2b or consensus-interferon (CIFN) plus ribavirin
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
